ID   DUL LCL
AC   CVCL_XA38
DR   Wikidata; Q93533346
RX   PubMed=2155117;
RX   PubMed=2156585;
CC   Doubling time: 48-60 hours (PubMed=2156585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=2156585; DOI=10.1007/BF01720278;
RA   Janssen, Ottmar
RA   Heinze, Barbara
RA   Bartram, Claus Rainer
RA   Pawlita, Michael
RA   Binder, Thomas
RA   Heimpel, Hermann
RA   Diehl, Klaus
RA   Kabelitz, Dieter
RT   "Establishment and characterization of a new Epstein-Barr virus
RT   transformed cell line from a human B cell lymphoma.";
RL   Blut 60:206-212(1990).
//
RX   PubMed=2155117; DOI=10.1002/eji.1830200103;
RA   Janssen, Ottmar
RA   Gillis, Steven
RA   Kabelitz, Dieter
RT   "In vitro transformation by Epstein-Barr virus induces a switch in
RT   growth factor and anti-IgM responsiveness in a human leukemic B cell
RT   clone.";
RL   Eur. J. Immunol. 20:7-14(1990).
//